PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24505400-5	2014	In conclusion, sulindac and its metabolites synergistically increase the anticancer effects of beta-lapachone primarily by increasing NQO1 activity and expression, and these two drugs may provide a novel combination therapy for lung cancers.	Sulindac	15-23	NAD(P)H quinone dehydrogenase 1	Homo sapiens	134-138